Literature DB >> 17286226

Vasodilating mechanisms of testosterone.

O Yildiz1, M Seyrek.   

Abstract

The increased incidence of cardiovascular disease in man compared with premenopausal women suggests an unfavourable effect of male sex hormone testosterone on the cardiovascular system. However, numerous clinical and epidemiological studies reported a controversial relationship between testosterone and cardiovascular disease. Furthermore, an increasing amount of evidence indicate that testosterone can exert acute vasorelaxing effects, VIA non-genomic mechanisms. These effects involve primarily the vascular smooth muscle, without requiring the presence of endothelium, although an endothelial contribution is apparent in some studies. To date, the mechanism behind the vasodilatory action of testosterone is still under debate and might be through either activation of K (+) channels or blockade of Ca (2+) channels in vascular muscle cells. The purpose of this article is to review the evidence regarding the vasodilating effect of testosterone as well as its mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286226     DOI: 10.1055/s-2007-949657

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  11 in total

1.  The vasodilatory effect of testosterone on renal afferent arterioles.

Authors:  Yan Lu; Yiling Fu; Ying Ge; Luis A Juncos; Jane F Reckelhoff; Ruisheng Liu
Journal:  Gend Med       Date:  2012-03-22

2.  Hypotestosteronemia is an important factor for the development of hypertension: elevated blood pressure in orchidectomized conscious rats is reversed by different androgens.

Authors:  Mercedes Perusquía; Daniela Contreras; Nieves Herrera
Journal:  Endocrine       Date:  2019-06-15       Impact factor: 3.633

3.  Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition.

Authors:  E Alvarez; E Cairrão; M Morgado; C Morais; I Verde
Journal:  Adv Pharmacol Sci       Date:  2010-03-30

4.  Testosterone delays vascular smooth muscle cell senescence and inhibits collagen synthesis via the Gas6/Axl signaling pathway.

Authors:  Yan-qing Chen; Jing Zhao; Cheng-wei Jin; Yi-hui Li; Meng-xiong Tang; Zhi-hao Wang; Wei Zhang; Yun Zhang; Li Li; Ming Zhong
Journal:  Age (Dordr)       Date:  2016-05-20

Review 5.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

6.  Testosterone, endothelial health, and erectile function.

Authors:  Angela Castela; Pedro Vendeira; Carla Costa
Journal:  ISRN Endocrinol       Date:  2011-09-06

7.  Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy.

Authors:  Jia Yu; Gezhi Xu; Qing Chang; Xiaofeng Ye; Lei Li; Chunhui Jiang; Qi Zhao
Journal:  J Ophthalmol       Date:  2019-08-14       Impact factor: 1.909

8.  Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use.

Authors:  Daniel Brill; Desiree Albert; Taylor Fields; Shravani Mikkilineni; David Crandall; Hua Gao
Journal:  Am J Ophthalmol Case Rep       Date:  2019-06-05

9.  Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases.

Authors:  Svetlana Kalinchenko; Alexandr Zemlyanoy; Louis J Gooren
Journal:  Cardiovasc Diabetol       Date:  2009-03-28       Impact factor: 9.951

10.  Testosterone attenuates hypoxia-induced hypertension by affecting NRF1-mediated transcriptional regulation of ET-1 and ACE.

Authors:  Shan Jiang; Guijuan Chen; Zhihui Yang; Dan Wang; Yapeng Lu; Li Zhu; Xueting Wang
Journal:  Hypertens Res       Date:  2021-07-13       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.